Commentary

Evidence-Based Medicine

Volumn 6, Issue 4, 2001, Pages 114-

  Groeneveld, P W ^a   Hlatky, M A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

CLINICAL RESEARCH; CONTROLLED STUDY; CORONARY STENT; COST EFFECTIVENESS ANALYSIS; DRUG CONTRAINDICATION; DRUG COST; HEART SURGERY; HUMAN; ISCHEMIC HEART DISEASE; NOTE; SIDE EFFECT;

EID: 0035191185     PISSN: 13565524     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebm.6.4.114     Document Type: Note

References (3)

1. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
2. Clopidogrel as adjunctive antiplatelet therapy during coronary stenting
3. Thrombotic thrombocytopenic purpura associated with clopidogrel